Evidence map›Paper›PMID 42835902›Full record

ArticleJournal of ophthalmic & vision research2026

Mathematical Model to Assess Mutational Burden in Retinal Dystrophy Patients Negative to Mendelian Genetic Tests and Carriers of Multiple Recessive Variants.

Maria Chiara Medori, Alessandro Macchia, Paolo Enrico Maltese, Jan Miertuš, Francesca Cristofoli, Ornela Gordani, Xhilda Dhamo, Eglantina Kalluci, Dominika Vešelényiová, Stanislav Miertuš and 9 more

Abstract read
In one paragraph

Article in Journal of ophthalmic & vision research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Maria Chiara MedoriMAGI'S LAB, Rovereto, Italy.
Alessandro MacchiaMAGI'S LAB, Rovereto, Italy.
Paolo Enrico MalteseMAGI'S LAB, Rovereto, Italy.
Jan MiertušMAGI'S LAB, Rovereto, Italy.
Francesca CristofoliMAGI EUREGIO, Bolzano, Italy.
Ornela GordaniDepartment of Applied Mathematics, Faculty of Natural Sciences, University of Tirana, Albania.
Xhilda DhamoDepartment of Applied Mathematics, Faculty of Natural Sciences, University of Tirana, Albania.
Eglantina KalluciDepartment of Applied Mathematics, Faculty of Natural Sciences, University of Tirana, Albania.
Dominika VešelényiováDepartment of Biology, Institute of Biology and Biotechnology, Faculty of Natural Sciences, University of Ss. Cyril and Methodius, Trnava, Slovakia.
Stanislav MiertušDepartment of Biotechnology, Institute of Biology and Biotechnology, Faculty of Natural Sciences, University of Ss. Cyril and Methodius in Trnava, Trnava, Slovakia.
Iveta Dirgová LuptákováInstitute of Computer Technologies and Informatics, Faculty of Natural Sciences, University of Ss. Cyril and Methodius, Trnava, Slovakia.
Jiří PospíchalInstitute of Computer Technologies and Informatics, Faculty of Natural Sciences, University of Ss. Cyril and Methodius, Trnava, Slovakia.
Rashid AhmedNick Holonyak Jr. Micro and Nanotechnology Laboratory, University of Illinois, IL, USA.
Andrea BerniniDepartment of Biotechnology, Chemistry and Pharmacy, University of Siena, Siena, Italy.
Giorgio PlacidiOphthalmology Unit, Fondazione Policlinico A. Gemelli, Rome, Italy.
Benedetto FalsiniOphthalmology Unit, Fondazione Policlinico A. Gemelli, Rome, Italy.
Pietro ChiurazziMedical Genetics, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy.
Dror RosentraubMAGI'S LAB, Rovereto, Italy.
Matteo BertelliMAGI'S LAB, Rovereto, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Despite advancements in genetic testing, a significant number of patients with retinal dystrophy receive negative test results due to single-allele mutations in genes with autosomal recessive inheritance patterns. This study aimed to address this diagnostic challenge by proposing a preliminary mathematical model based on mutational burden analysis. This approach can identify unique digenic or oligogenic combinations, potentially prioritizing them for further investigation. Methods: We retrospectively analyzed clinical and genetic data from 527 subjects comprising 453 patients with retinal dystrophies (cases) and 74 controls and created semi-synthetic datasets. Protein-protein interaction networks were analyzed, and the significance of mutational burden in specific molecular pathways was investigated. Results: Our model identified two metabolic pathways that are highly correlated to each other, namely "retinoid cycle disease events" and "canonical retinoid cycle in rods (twilight vision)." These pathways were significantly impacted by the burden of variants we found in the case group. Moreover, the gene combinations ( Conclusion: The proposed preliminary model provides a systematic approach to calculate the mutational burden in patients with retinal dystrophies and previous negative genetic test results. Moreover, the bioinformatic analysis facilitated the identification of recurrent combinations of involved genes, suggesting possible new digenic or oligogenic inheritance patterns.

Indexed as

Digenic InheritanceMutational BurdenProtein–Protein Interaction NetworksRetinal DystrophiesRetinoid Cycle Pathway

Identifiers

PMID42835902
PMCPMC13636023

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.